Omics-based Clinical Trials Market Size, Share & Trends Report

Omics-based Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies), By Indication, By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-4-68039-905-9
Number of Report Pages: 120
Format: PDF, Horizon Databook

Historical Range: 2018 - 2024
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Omics-based Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
Omics-based Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)
- Interventional Studies
- Observational Studies
- Expanded Access Studies
Omics-based Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Autoimmune/inflammation
- Pain management
- Oncology
- CNS conditions
- Diabetes
- Obesity
- Cardiovascular
- Others
Omics-based Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Omics-based Clinical Trials Market, by Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - North America Omics-based Clinical Trials Market, by Study Design
    - Interventional Studies
    - Observational Studies
    - Expanded Access Studies
  - North America Omics-based Clinical Trials Market, by Indication
    - Autoimmune/inflammation
    - Pain management
    - Oncology
    - CNS conditions
    - Diabetes
    - Obesity
    - Cardiovascular
    - Others
  - U.S.
    - U.S. Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - U.S. Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - U.S. Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Canada
    - Canada Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Canada Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Canada Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Mexico
    - Mexico Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Mexico Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Mexico Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
- Europe
  - Europe Omics-based Clinical Trials Market, by Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Europe Omics-based Clinical Trials Market, by Study Design
    - Interventional Studies
    - Observational Studies
    - Expanded Access Studies
  - Europe Omics-based Clinical Trials Market, by Indication
    - Autoimmune/inflammation
    - Pain management
    - Oncology
    - CNS conditions
    - Diabetes
    - Obesity
    - Cardiovascular
    - Others
  - UK
    - UK Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - UK Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - UK Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Germany
    - Germany Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Germany Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Germany Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - France
    - France Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - France Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - France Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Italy
    - Italy Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Italy Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Italy Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Spain
    - Spain Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Spain Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Spain Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Denmark
    - Denmark Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Denmark Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Denmark Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Sweden
    - Sweden Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Sweden Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Sweden Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Norway
    - Norway Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Norway Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Norway Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
- Asia Pacific
  - Asia Pacific Omics-based Clinical Trials Market, by Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Asia Pacific Omics-based Clinical Trials Market, by Study Design
    - Interventional Studies
    - Observational Studies
    - Expanded Access Studies
  - Asia Pacific Omics-based Clinical Trials Market, by Indication
    - Autoimmune/inflammation
    - Pain management
    - Oncology
    - CNS conditions
    - Diabetes
    - Obesity
    - Cardiovascular
    - Others
  - Japan
    - Japan Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Japan Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Japan Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - China
    - China Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - China Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - China Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - India
    - India Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - India Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - India Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Australia
    - Australia Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Australia Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Australia Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - South Korea
    - South Korea Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - South Korea Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - South Korea Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Thailand
    - Thailand Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Thailand Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Thailand Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
- Latin America
  - Latin America Omics-based Clinical Trials Market, by Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Latin America Omics-based Clinical Trials Market, by Study Design
    - Interventional Studies
    - Observational Studies
    - Expanded Access Studies
  - Latin America Omics-based Clinical Trials Market, by Indication
    - Autoimmune/inflammation
    - Pain management
    - Oncology
    - CNS conditions
    - Diabetes
    - Obesity
    - Cardiovascular
    - Others
  - Brazil
    - Brazil Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Brazil Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Brazil Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Argentina
    - Argentina Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Argentina Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Argentina Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
- MEA
  - MEA Omics-based Clinical Trials Market, by Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - MEA Omics-based Clinical Trials Market, by Study Design
    - Interventional Studies
    - Observational Studies
    - Expanded Access Studies
  - MEA Omics-based Clinical Trials Market, by Indication
    - Autoimmune/inflammation
    - Pain management
    - Oncology
    - CNS conditions
    - Diabetes
    - Obesity
    - Cardiovascular
    - Others
  - South Africa
    - South Africa Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - South Africa Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - South Africa Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Saudi Arabia
    - Saudi Arabia Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Saudi Arabia Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Saudi Arabia Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - UAE
    - UAE Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - UAE Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - UAE Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others
  - Kuwait
    - Kuwait Omics-based Clinical Trials Market, by Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Kuwait Omics-based Clinical Trials Market, by Study Design
      - Interventional Studies
      - Observational Studies
      - Expanded Access Studies
    - Kuwait Omics-based Clinical Trials Market, by Indication
      - Autoimmune/inflammation
      - Pain management
      - Oncology
      - CNS conditions
      - Diabetes
      - Obesity
      - Cardiovascular
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.